Literature DB >> 31630732

PET/CT for Evaluation of Ovarian Cancer.

Jukka Kemppainen1, Johanna Hynninen2, Johanna Virtanen3, Marko Seppänen4.   

Abstract

Ovarian cancer is the leading cause of death from gynecologic cancer in the developed countries. It is usually diagnosed in advanced stage since it is often symptomless or symptoms are nonspecific in early course of the disease. It has a high recurrence rate and poor prognosis in advanced disease. Ovarian cancer has distinct type of disease spread in abdomen and above diaphragm. Surgery is irreplaceable in staging but multimodality imaging approach is often needed during the diagnosis, treatment monitoring, and follow-up of patients with ovarian cancer, typically ultrasound, CT, MRI and PET/CT are the main modalities used. The current clinical role of PET/CT in evaluation of ovarian cancer during staging, treatment prognostication and response assessment, and in disease recurrence is discussed in this review compared to conventional imaging.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2019        PMID: 31630732     DOI: 10.1053/j.semnuclmed.2019.06.010

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  13 in total

Review 1.  Imaging spectrum of mesenteric masses.

Authors:  Radwan Diab; Mayur Virarkar; Mohammed Saleh; Sherif Elsheif; Sanaz Javadi; Priya Bhosale; Silvana Faria
Journal:  Abdom Radiol (NY)       Date:  2020-11

2.  Lymphatic tuberculosis after lymphadenectomy for ovarian cancer: a case report.

Authors:  Shuang Sheng; Bo Chi; Yan Kuang
Journal:  Gland Surg       Date:  2022-02

Review 3.  Diagnostic performance of PET/CT and PET/MR in the management of ovarian carcinoma-a literature review.

Authors:  Mayur Virarkar; Dhakshinamoorthy Ganeshan; Anjalie Tara Gulati; Sarah Palmquist; Revathy Iyer; Priya Bhosale
Journal:  Abdom Radiol (NY)       Date:  2020-11-11

4.  Predicting tumor response and outcome of second-look surgery with 18F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in stage IIIc-IV FIGO ovarian cancer.

Authors:  Nicolas Aide; Pauline Fauchille; Elodie Coquan; Gwenael Ferron; Pierre Combe; Jérome Meunier; Jerôme Alexandre; Dominique Berton; Alexandra Leary; Gaétan De Rauglaudre; Nathalie Bonichon; Eric Pujade Lauraine; Florence Joly
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-11-21       Impact factor: 9.236

5.  Comprehensive Analysis of Tumor Microenvironment Identified Prognostic Immune-Related Gene Signature in Ovarian Cancer.

Authors:  Na Li; Biao Li; Xianquan Zhan
Journal:  Front Genet       Date:  2021-02-10       Impact factor: 4.599

6.  Evaluation of patients with advanced epithelial ovarian cancer before primary treatment: correlation between tumour burden assessed by [18F]FDG PET/CT volumetric parameters and tumour markers HE4 and CA125.

Authors:  Ariel Glickman; Pilar Paredes; Núria Carreras-Diéguez; Aida Niñerola-Baizán; Lydia Gaba; Jaume Pahisa; Pere Fusté; Marta Del Pino; Berta Díaz-Feijóo; Eduardo González-Bosquet; Núria Agustí; Nuria Sánchez-Izquierdo; David Fuster; Andrés Perissinotti; Inmaculada Romero; Esther Fernández-Galán; Josep Lluís Carrasco; Blanca Gil-Ibáñez; Aureli Torné
Journal:  Eur Radiol       Date:  2021-09-29       Impact factor: 7.034

7.  Assessment of Lymph Node Involvement with PET-CT in Advanced Epithelial Ovarian Cancer. A FRANCOGYN Group Study.

Authors:  Antoine Tardieu; Lobna Ouldamer; François Margueritte; Lauranne Rossard; Aymeline Lacorre; Nicolas Bourdel; Guillaume Lades; Camille Sallée; Jacques Monteil; Tristan Gauthier
Journal:  J Clin Med       Date:  2021-02-05       Impact factor: 4.241

8.  Evaluation of an Automatic Classification Algorithm Using Convolutional Neural Networks in Oncological Positron Emission Tomography.

Authors:  Pierre Pinochet; Florian Eude; Stéphanie Becker; Vijay Shah; Ludovic Sibille; Mathieu Nessim Toledano; Romain Modzelewski; Pierre Vera; Pierre Decazes
Journal:  Front Med (Lausanne)       Date:  2021-02-26

9.  Radiomics Analysis of PET and CT Components of 18F-FDG PET/CT Imaging for Prediction of Progression-Free Survival in Advanced High-Grade Serous Ovarian Cancer.

Authors:  Xihai Wang; Zaiming Lu
Journal:  Front Oncol       Date:  2021-04-13       Impact factor: 6.244

Review 10.  Ovarian cancer staging: What the surgeon needs to know.

Authors:  Lucas Roberto Lelis Botelho de Oliveira; Natally Horvat; Pamela Ines Causa Andrieu; Pedro Sergio Brito Panizza; Giovanni Guido Cerri; Publio Cesar Cavalcante Viana
Journal:  Br J Radiol       Date:  2021-07-21       Impact factor: 3.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.